P
Pharming Group N.V. ADS each representing 10
Biotechnology: Pharmaceutical Preparations company
Key Metrics of Pharming Group N.V. ADS each representing 10
Revenue€186M▲ 0.0% YoYFY 2020
Operating income€66.7M▲ 0.0% YoY
Net profit€33.0M▲ 0.0% YoY
Shareholders' equity€149M
Market cap$899MPHAR · $12.73
Competitors10identified
About Pharming Group N.V. ADS each representing 10
Sectors
Company details
- Listed
- Nasdaq: PHAR
Operational Areas of Pharming Group N.V. ADS each representing 10
Pharmaceuticals & Healthcare›Biotechnology & Vaccines
Company summary
Legal namePharming Group N.V. ADS each representing 10
TickerPHAR
ExchangeNasdaq
CountryNetherlands
SEC CIK0001828316
Listed since—
IndustryBiotechnology: Pharmaceutical Preparations
SectorPharmaceuticals & Healthcare · Biotechnology & Vaccines
Website—
US market & SEC filings
PHAR · Nasdaq · SEC CIK 0001828316
Last price · 03 Nov 2026
$12.73
+4.09%
Market cap$899M
P/E—On FY 2020 diluted EPS
Volume19,961
SectorHealth CareBiotechnology: Pharmaceutical Preparations
Country · IPONetherlands
PHAR share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered office—
GSTIN—
Email—
Website—
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Pharming Group N.V. ADS each representing 10
Competitors10identified
Countries2most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Part of Vertex Pharmaceuticals. | vrtx.com | 1991 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | gsk.com | 2022 | United Kingdom | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | modernatx.com | 2018 | United States | |
 Becton Dickinson |
Biotechnology & Vaccines · Pharmaceuticals & Healthcare | bd.com | — | United States |
| Part of Illumina. | illumina.com | 2000 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | guardanthealth.com | 2018 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | exelixis.com | 2000 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | revvity.com | — | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | neurocrine.com | 1996 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | biomarin.com | 1999 | United States |
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.
Filings
No filings on record yet.